310 related articles for article (PubMed ID: 10759060)
1. Hormonal replacement regimens and bleeding.
Dören M
Maturitas; 2000 Jan; 34 Suppl 1():S17-23. PubMed ID: 10759060
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
[TBL] [Abstract][Full Text] [Related]
3. Endometrial safety of hormone replacement therapy: review of literature.
Van Gorp T; Neven P
Maturitas; 2002 Jun; 42(2):93-104. PubMed ID: 12065168
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
[TBL] [Abstract][Full Text] [Related]
5. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
6. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of fully transdermal hormone replacement in sequential or continuous therapy at two doses of progestogen in postmenopausal women.
Ylikorkala O; Rozenberg S
Maturitas; 2000 Dec; 37(2):83-93. PubMed ID: 11137327
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
9. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
Gambrell RD
Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
[TBL] [Abstract][Full Text] [Related]
10. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
[TBL] [Abstract][Full Text] [Related]
11. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
[TBL] [Abstract][Full Text] [Related]
12. The endometrium: effects of estrogen and estrogen-progestogen replacement therapy.
Samsioe G
Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():84-92. PubMed ID: 7874191
[TBL] [Abstract][Full Text] [Related]
13. Endometrial safety and bleeding with HRT: what's new?
Sturdee DW
Climacteric; 2007 Oct; 10 Suppl 2():66-70. PubMed ID: 17882676
[TBL] [Abstract][Full Text] [Related]
14. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
Furness S; Roberts H; Marjoribanks J; Lethaby A; Hickey M; Farquhar C
Cochrane Database Syst Rev; 2009 Apr; (2):CD000402. PubMed ID: 19370558
[TBL] [Abstract][Full Text] [Related]
15. HRT dosing regimens: continuous versus cyclic-pros and cons.
Shoupe D
Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
Furness S; Roberts H; Marjoribanks J; Lethaby A
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD000402. PubMed ID: 22895916
[TBL] [Abstract][Full Text] [Related]
17. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
Cameron ST; Critchley HO; Glasier AF; Williams AR; Baird DT
Br J Obstet Gynaecol; 1997 Oct; 104(10):1184-90. PubMed ID: 9332998
[TBL] [Abstract][Full Text] [Related]
18. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
Sturdee DW
Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and bleeding disorders.
Römer T
Gynecol Endocrinol; 2006 Mar; 22(3):140-4. PubMed ID: 16835075
[TBL] [Abstract][Full Text] [Related]
20. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
